Upstream Bio Inc (NASDAQ:UPB) shares, rose in value on Friday, May 09, with the stock price down by -0.23% to the previous day’s close as strong demand from buyers drove the stock to $8.82.
Actively observing the price movement in the last trading, the stock closed the session at $8.84. Referring to stock’s 52-week performance, its high was $29.46, and the low was $5.14. On the whole, UPB has fluctuated by 35.07% over the past month.
With the market capitalization of Upstream Bio Inc currently standing at about $474.46 million, investors are eagerly awaiting this quarter’s results, scheduled for in June.
The stock’s technical analysis shows that the price of UPB currently trading nearly 1.54% and 9.11% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 54.24, while the 7-day volatility ratio is showing 12.66% which for the 30-day chart, stands at 11.85%. Furthermore, Upstream Bio Inc (UPB)’s average true range (ATR) is 0.93.
Data on historical trading for Upstream Bio Inc (NASDAQ:UPB) indicates that the trading volumes over the past 3 months, they’ve averaged 278.36K. According to company’s latest data on outstanding shares, there are 53.64 million shares outstanding.
Nearly 64.29% of Upstream Bio Inc’s shares belong to company insiders and institutional investors own 40.11% of the company’s shares. The stock has fallen by -46.35% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the UPB stock heading into the next quarter.
